NCT06602856 Point-of-care-ultrasound in Swiss Air Rescue Rega
| NCT ID | NCT06602856 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Insel Gruppe AG, University Hospital Bern |
| Condition | Point-of-care-ultrasound |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2024-11-01 |
| Primary Completion | 2026-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2024-11-01 with a primary completion date of 2026-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of the study is, on the one hand, to objectively investigate the patient-oriented benefits of prehospital point-of-care ultrasound (POCUS) examinations under the conditions of the helicopter emergency medical services (HEMS) in Switzerland. On the other hand, the study will show what the diagnostic quality of prehospital POCUS examinations is and how emergency medical teams can be trained to use POCUS in the future. HEMS crew members will answer a short online questionaire about how findings of their POCUS examination has influenced their medical treatment, diagnosis and selection of target hospital for the patient (primary outcome parameters). In addition, a study nurse will query the findings of the in-hospital diagnostic tests and compare them with the findings of the pre-hospital POCUS examination. This will enable the investigators to evaluate the diagnostic quality of the prehospital POCUS examination and to identify which findings are often not recognised in the POCUS. The subjective satisfaction and assessment of the benefit of the POCUS examination by the respective users will also be recorded (secondary outcome parameters).
Eligibility Criteria
Inclusion Criteria: * All patients in whom the treating Rega team uses POCUS pre-hospital * existing written General Consent (with permission to use patient data for research) Exclusion Criteria: * Age \<18 years
Contact & Investigator
Jürgen Knapp, Dr.
PRINCIPAL INVESTIGATOR
Bern University Hospital
Frequently Asked Questions
Who can join the NCT06602856 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Point-of-care-ultrasound. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06602856 currently recruiting?
Yes, NCT06602856 is actively recruiting participants. Contact the research team at juergen.knapp@insel.ch for enrollment information.
Where is the NCT06602856 trial being conducted?
This trial is being conducted at Zurich, Switzerland.
Who is sponsoring the NCT06602856 clinical trial?
NCT06602856 is sponsored by Insel Gruppe AG, University Hospital Bern. The principal investigator is Jürgen Knapp, Dr. at Bern University Hospital. The trial plans to enroll 1,000 participants.